Biotech (India) Technologies Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 06-01-2025
- Paid Up Capital ₹ 3.00 M
as on 06-01-2025
- Company Age 17 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.37 Cr
as on 06-01-2025
- Revenue 11.66%
(FY 2022)
- Profit 13.59%
(FY 2022)
- Ebitda 18.18%
(FY 2022)
- Net Worth 10.88%
(FY 2022)
- Total Assets 2.04%
(FY 2022)
About Biotech (India) Technologies
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹2.37 Cr.
Hari Charan, Kanta Tiwari, Anshul Tiwari, and One other member serve as directors at the Company.
- CIN/LLPIN
U24211MP2007PTC020032
- Company No.
020032
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Nov 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Bhopal, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Biotech (India) Technologies?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hari Charan  | Director | 27-Nov-2007 | Current |
| Kanta Tiwari | Director | 27-Nov-2007 | Current |
| Anshul Tiwari | Director | 27-Nov-2007 | Current |
| Rahul Tiwari | Director | 27-Nov-2007 | Current |
Financial Performance of Biotech (India) Technologies.
Biotech (India) Technologies Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.66% increase. The company also saw a substantial improvement in profitability, with a 13.59% increase in profit. The company's net worth Soared by an impressive increase of 10.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biotech (India) Technologies?
In 2017, Biotech (India) Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Nov 2020 | ₹1.86 M | Open |
Others Creation Date: 14 Oct 2016 | ₹9.30 M | Open |
Bank Of India Creation Date: 17 Aug 2009 | ₹1.25 Cr | Open |
How Many Employees Work at Biotech (India) Technologies?
Unlock and access historical data on people associated with Biotech (India) Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biotech (India) Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biotech (India) Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
